Pharma Stocks
-
How Investors May Respond To Amylyx Pharmaceuticals (AMLX) Narrowed 2025 Losses And Expanded Shelf Capacity
In March 2026, Amylyx Pharmaceuticals reported fourth-quarter and full-year 2025 results showing a reduced net loss of US$33.0 million for…
Read More » -
The Bull Case For InnoCare Pharma (SEHK:9969) Could Change Following First-in-China VAV1 Degrader Trial Start
InnoCare Pharma recently dosed the first healthy volunteer in a China clinical trial of ICP-538, an oral VAV1-directed molecular glue…
Read More » -
US60041A1025) Eyes Catalyst Ahead of ACC.26 Data Presentation
Milestone Pharmaceuticals (MIST), a clinical-stage biotech focused on cardiovascular treatments, nears a key data readout at ACC.26 as shares hover…
Read More » -
Piramal Pharma Ltd Stock Hits 52-Week Low Amidst Continue…
Stock Price Movement and Market Context On 16 Mar 2026, Piramal Pharma Ltd’s stock touched an intraday low of Rs.134.8,…
Read More » -
Why Clarity Pharmaceuticals (ASX:CU6) Is Up 7.0% After AMPLIFY Trial Consent Completion And What’s Next
Clarity Pharmaceuticals recently reported that its pivotal Phase III AMPLIFY trial for prostate cancer imaging agent 64Cu-SAR-bisPSMA has now consented…
Read More » -
Steady Growth Amid Global Pharma Shifts
Aspen Pharmacare Holdings Ltd stock (ISIN: ZAE000066692) maintains resilience in a volatile market, driven by strong generics demand and strategic…
Read More » -
US53227K1025) Faces Uncertainty Amid Delisting Risk and Pipeline Focus
aTyr Pharma Inc stock (ISIN: US53227K1025) trades at a subdued market cap of around $131 million as delisting warnings emerge,…
Read More » -
US53227K1025) Faces Uncertainty Amid Delisting Risk and Pipeline Focus
aTyr Pharma Inc stock (ISIN: US53227K1025) trades at a subdued market cap of around $131 million as delisting warnings emerge,…
Read More » -
CH0012032048) Faces Weekly Pressure Amid Mixed Analyst Views and Divid
Roche Holding AG stock (ISIN: CH0012032048) closed at 320.70 CHF on March 13, 2026, up 0.79% daily but down 8.76%…
Read More » -
DE000A1MMCC8) Faces Headwinds Amid German Pharma Wholesale Slowdown
Medios AG stock (ISIN: DE000A1MMCC8) trades under pressure on Xetra as Q4 results reveal margin erosion and slower revenue growth…
Read More »